Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer
about
Vapor of volatile oils from Litsea cubeba seed induces apoptosis and causes cell cycle arrest in lung cancer cellsThe PI3K/Akt Pathway in Tumors of Endocrine TissuesTargeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer CellsPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsMaximising the potential of AKT inhibitors as anti-cancer treatmentsThe critical role of Akt in cardiovascular functionEssential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicityKCTD20, a relative of BTBD10, is a positive regulator of AktInhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomasAF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling.Glycogen synthase kinase 3 protein kinase activity is frequently elevated in human non-small cell lung carcinoma and supports tumour cell proliferation.Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptorPhosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancerBariatric surgery in morbidly obese insulin resistant humans normalises insulin signalling but not insulin-stimulated glucose disposal.Diverse involvement of isoforms and gene aberrations of Akt in human lung carcinomas.Non-canonical Activation of Akt in Serum-Stimulated Fibroblasts, Revealed by Comparative Modeling of Pathway DynamicsRasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3.A bead-based western for high-throughput cellular signal transduction analyses.Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulationDiscovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2.Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells.Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFNF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase.Site-specific activation of AKT protects cells from death induced by glucose deprivation.Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastomaThe Paradox of Akt-mTOR Interactions.Signalling specificity in the Akt pathway in breast cancer.Impact of resistance exercise on ribosome biogenesis is acutely regulated by post-exercise recovery strategies.ERK and AKT phosphorylation status in lung cancer and emphysema using nanocapillary isoelectric focusing.mTOR in health and in sickness.Hypoxia-Driven Mechanism of Vemurafenib Resistance in MelanomaFibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells.A comparative survey of functional footprints of EGFR pathway mutations in human cancers.Parkinson's disease-associated DJ-1 mutations increase abnormal phosphorylation of tau protein through Akt/GSK-3β pathways.Rac-1 superactivation triggers insulin-independent glucose transporter 4 (GLUT4) translocation that bypasses signaling defects exerted by c-Jun N-terminal kinase (JNK)- and ceramide-induced insulin resistance.Antibiotic drug tigecycline reduces neuroblastoma cells proliferation by inhibiting Akt activation in vitro and in vivo.
P2860
Q21090858-16502558-12BA-4545-93EF-3FF09F1FD21DQ26770404-9AC6BFBE-37F5-4C01-A9B7-AEC1FA3D1D46Q26798203-179B1FB3-7A54-45D1-9DC7-59C3EC4639C0Q26862544-7F285B7D-2A6C-404B-9D79-3FE999642B60Q28072254-5495AB67-5FCB-4A09-A54E-D01AD950F933Q28083829-F64BCBC6-1262-445F-BA5F-104623A8F1A4Q28236954-233ED90D-6D43-4D0D-B05A-FA37C790FE8DQ28590940-0B40B33C-1219-4F34-AA88-49C5451D9CA0Q33574190-2978484A-973F-4EB9-9D19-9E39E3C70F71Q33755044-47427932-A2C3-4DFB-A1E2-DC3DAEC3B615Q34092837-5DB82F76-4089-4D6F-8278-557BC4BEB048Q34654039-3F602E6E-3B20-4AAF-9B73-25B3E0081A62Q34796287-D25C826C-B068-4CBC-979D-1DF13848BDCEQ35256618-8B0BB200-84F9-440F-94E6-CEC0BD4955E7Q35393067-119D0936-62AD-46CD-B27E-CFECAE56D26CQ35754270-037D46C1-6F35-4A85-B250-6BB09A9D5E28Q35836933-72DB2CBD-0EDE-4408-B345-700DDACFF191Q35925830-07C2CE26-488D-4B43-93A9-6102DF42C6B2Q36141854-58D96784-7993-42BD-A81B-EDAD7B7169C1Q36299173-1376E5FA-4412-4FF4-88BC-A19F7A91CF52Q36340315-625E2411-1131-4F42-92F0-6E178C551F95Q36688994-5F51746F-A530-498D-9158-D8C426E5F9FAQ36760689-8B79622B-CA70-4914-9DE8-65861D91A5FCQ37156395-B1F36E3B-062C-474E-A0C8-5DE7F8D3C358Q37178573-1A8025E1-D435-44AC-902A-D635B4425D3CQ37233198-3FA6B0B9-D05B-4DFC-9A24-16CBC27E88E8Q37417611-B9A48E72-079F-49B1-835A-20476996EE57Q37520595-DBD2C167-A5E6-417C-8C0D-D9DFC1E5CB11Q38117148-960EF8E4-E57C-408A-B2CA-3D5E0DCEAD26Q38252278-96B3602F-456E-4D8B-B474-D804380B569FQ38564905-0E8686A5-C67B-4348-BC27-C29949E4AD2BQ38583728-983A8F41-A420-405F-B1B0-FA7E14DCCCECQ38590634-90E3A799-BBB4-44F8-B1DB-130D7E88A025Q38755819-CF01381C-23DE-4764-99AE-81A1DABC52D0Q38959812-9358F727-24BB-4D55-B5D8-70DAFAF6CCB7Q39013961-6BA181AB-F762-4272-964E-F0644BCF0E5DQ39069318-8E702871-5E37-411E-88D3-4513DF8075FDQ39104616-B8F141F0-5718-4089-AF27-541723BE9CC7Q39156707-04F852E6-FCD8-4E28-A74D-962447EC793BQ40188774-63B95E5B-B666-4B51-9D5D-436BDB74110A
P2860
Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Akt phosphorylation on Thr308 ...... man non-small cell lung cancer
@ast
Akt phosphorylation on Thr308 ...... man non-small cell lung cancer
@en
type
label
Akt phosphorylation on Thr308 ...... man non-small cell lung cancer
@ast
Akt phosphorylation on Thr308 ...... man non-small cell lung cancer
@en
prefLabel
Akt phosphorylation on Thr308 ...... man non-small cell lung cancer
@ast
Akt phosphorylation on Thr308 ...... man non-small cell lung cancer
@en
P2093
P2860
P356
P1476
Akt phosphorylation on Thr308 ...... man non-small cell lung cancer
@en
P2093
D J E Elder
E C Thomas
J M Tavaré
L Phillips
M R Hetzel
P2860
P2888
P304
P356
10.1038/BJC.2011.132
P407
P577
2011-04-19T00:00:00Z